Publications

(1) Griffante G, Gugliesi F, Pasquero S, Dell’Oste V, Biolatti M, Salinger AJ, et al. Human cytomegalovirus-induced host protein citrullination is crucial for viral replication. Nat Commun 2021;12(1).
(2) Mola S, Pinton G, Erreni M, Corazzari M, Andrea MD, Grolla AA, et al. Inhibition of the histone methyltransferase ezh2 enhances protumor monocyte recruitment in human mesothelioma spheroids. Int J Mol Sci 2021;22(9).
(3) Galitska G, Coscia A, Forni D, Steinbrueck L, De Meo S, Biolatti M, et al. Genetic Variability of Human Cytomegalovirus Clinical Isolates Correlates With Altered Expression of Natural Killer Cell-Activating Ligands and IFN-γ. Front Immunol 2021;12.
(4) Riva G, Albano C, Gugliesi F, Pasquero S, Pacheco SFC, Pecorari G, et al. HPV meets APOBEC: New players in head and neck cancer. Int J Mol Sci 2021;22(3):1-14.
(5) Quaglia M, Merlotti G, De Andrea M, Borgogna C, Cantaluppi V. Review viral infections and systemic lupus erythematosus: New players in an old story. Viruses 2021;13(2).
(6) Gugliesi F, Pasquero S, Griffante G, Scutera S, Albano C, Castillo Pacheco SF, et al. Human cytomegalovirus and autoimmune diseases: Where are we? Viruses 2021;13(2).
(7) Iannucci A, Caneparo V, Raviola S, Debernardi I, Colangelo D, Miggiano R, et al. Toll-like receptor 4-mediated inflammation triggered by extracellular IFI16 is enhanced by lipopolysaccharide binding. PLoS Pathog 2020;16(9).
(8) de Meo S, Dell'Oste V, Molfetta R, Tassinari V, Lotti LV, Vespa S, et al. Samhd1 phosphorylation and cytoplasmic relocalization after human cytomegalovirus infection limits its antiviral activity. PLoS Pathog 2020;16(9).
(9) Couté Y, Kraut A, Zimmermann C, Büscher N, Hesse A-, Bruley C, et al. Mass spectrometry-based characterization of the virion proteome, phosphoproteome, and associated kinase activity of human cytomegalovirus. Microorg 2020;8(6).
(10) Coscia A, Leone A, Rubino C, Galitska G, Biolatti M, Bertino E, et al. Risk of symptomatic infection after non-primary congenital cytomegalovirus infection. Microorg 2020;8(5).
(11) Biolatti M, Blangetti M, D’arrigo G, Spyrakis F, Cappello P, Albano C, et al. Strigolactone analogs are promising antiviral agents for the treatment of human cytomegalovirus infection. Microorg 2020;8(5).
(12) Gugliesi F, Coscia A, Griffante G, Galitska G, Pasquero S, Albano C, et al. Where do we stand after decades of studying human cytomegalovirus? Microorg 2020;8(5).
(13) Mozzi A, Biolatti M, Cagliani R, Forni D, Dell’Oste V, Pontremoli C, et al. Past and ongoing adaptation of human cytomegalovirus to its host. PLoS Pathog 2020;16(5).
(14) Dell’Oste V, Biolatti M, Galitska G, Griffante G, Gugliesi F, Pasquero S, et al. Tuning the Orchestra: HCMV vs. Innate Immunity. Front Microbiol 2020;11.
(15) Colombo G, Clemente N, Zito A, Bracci C, Colombo FS, Sangaletti S, et al. Neutralization of extracellular NAMPT (nicotinamide phosphoribosyltransferase) ameliorates experimental murine colitis. J Mol Med 2020;98(4):595-612.
(16) Lo Cigno I, Calati F, Borgogna C, Zevini A, Albertini S, Martuscelli L, et al. Human papillomavirus E7 oncoprotein subverts host innate immunity via Suv39H1-mediated epigenetic silencing of immune sensor genes. J Virol 2020;94(4).
(17) Riva G, Biolatti M, Pecorari G, Dell’oste V, Landolfo S. PYHIN proteins and HPV: Role in the pathogenesis of head and neck squamous cell carcinoma. Microorg 2020;8(1).
(18) De Andrea M, De Santis M, Caneparo V, Generali E, Sirotti S, Isailovic N, et al. Serum IFI16 and anti-IFI16 antibodies in psoriatic arthritis. Clin Exp Immunol 2020;199(1):88-96.
(19) Cheng AZ, Moraes SN, Attarian C, Yockteng-Melgar J, Jarvis MC, Biolatti M, et al. A conserved mechanism of APOBEC3 relocalization by herpesviral ribonucleotide reductase large subunits. J Virol 2019;9(23).
(20) Piccaluga PP, Navari M, Visani A, Rigotti F, Agostinelli C, Righi S, et al. Interferon gamma inducible protein 16 (IFI16) expression is reduced in mantle cell lymphoma. Heliyon 2019;5(11).
(21) Riva G, Pecorari G, Biolatti M, Pautasso S, Lo Cigno I, Garzaro M, et al. PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas. Mol Biol Rep 2019;46(3):3333-3347.
(22) Galitska G, Biolatti M, Griffante G, Gugliesi F, Pasquero S, Dell'Oste V, et al. Catch me if you can: The arms race between human cytomegalovirus and the innate immune system. Future Virol 2019;14(4):247-263.
(23) Manfredi M, Conte E, Barberis E, Buzzi A, Robotti E, Caneparo V, et al. Integrated serum proteins and fatty acids analysis for putative biomarker discovery in inflammatory bowel disease. J Proteomics 2019;195:138-149.
(24) Galitska G, Biolatti M, De Andrea M, Leone A, Coscia A, Bertolotti L, et al. Biological relevance of Cytomegalovirus genetic variability in congenitally and postnatally infected children. J Clin Virol 2018;108:132-140.
(25) Biolatti M, Dell’oste V, Scutera S, Gugliesi F, Griffante G, De Andrea M, et al. The viral tegument protein pp65 impairs transcriptional upregulation of IL-1β by human cytomegalovirus through inhibition of NF-kB activity. Viruses 2018;10(10).
(26) Pautasso S, Galitska G, Dell’Oste V, Biolatti M, Cagliani R, Forni D, et al. Strategy of human cytomegalovirus to escape interferon beta-induced APOBEC3G editing activity. J Virol 2018;92(19).
(27) Biolatti M, Gugliesi F, Dell'Oste V, Landolfo S. Modulation of the innate immune response by human cytomegalovirus. Infec Genet Evol 2018;64:105-114.
(28) Caneparo V, Landolfo S, Gariglio M, De Andrea M. The absent in melanoma 2-like receptor IFN-inducible protein 16 as an inflammasome regulator in systemic lupus erythematosus: The dark side of sensing microbes. Front Immunol 2018;9(MAY).
(29) Biolatti M, Dell’Oste V, De Andrea M, Landolfo S. The human cytomegalovirus tegument protein pp65 (pUL83): A key player in innate immune evasion. New Microbiol 2018;41(2):87-94.
(30) Albertini S, Cigno IL, Calati F, De Andrea M, Borgogna C, Dell'Oste V, et al. HPV18 persistence impairs basal and DNA ligand-mediated IFN-β and IFN-λ1 production through transcriptional repression of multiple downstream effectors of pattern recognition receptor signaling. J Immunol 2018;200(6):2076-2089.
(31) Biolatti M, Dell'Oste V, Pautasso S, Gugliesi F, von Einem J, Krapp C, et al. Human cytomegalovirus tegument protein pp65 (pUL83) dampens type I interferon production by inactivating the DNA sensor cGAS without affecting STING. J Virol 2018;92(6).
(32) Borgogna C, Olivero C, Lanfredini S, Calati F, De Andrea M, Zavattaro E, et al. β-HPV infection correlates with early stages of carcinogenesis in skin tumors and patient-derived xenografts from a kidney transplant recipient cohort. Front Microbiol 2018;9(FEB).
(33) Lanfredini S, Olivero C, Borgogna C, Calati F, Powell K, Davies K-, et al. HPV8 Field Cancerization in a Transgenic Mouse Model Is due to Lrig1+ Keratinocyte Stem Cell Expansion. J Invest Dermatol 2017;137(10):2208-2216.
(34) Piccaluga PP, Agostinelli C, Righi S, Ciccone M, Re MC, Musumeci G, et al. IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemia. APMIS 2017;125(6):511-522.
(35) Alunno A, Bartoloni E, Bistoni O, Gerli R, Caneparo V, Carubbi F, et al. Relevance of Interferon-Inducible Protein-16 Rather than Anti–Interferon-Inducible Protein-16 Autoantibodies as a Clinical and Pathogenic Biomarker in Primary Sjögren’s Syndrome: Comment on the Article by Baer et al. Arthritis Care Res 2017;69(3):453-454.
(36) Ragin C, Liu JC, Jones G, Shoyele O, Sowunmi B, Kennett R, et al. Prevalence of HPV infection in racial-ethnic subgroups of head and neck cancer patients. Carcinogenesis 2017;38(2):218-229.
(37) Caneparo V, Pastorelli L, Pisani LF, Bruni B, Prodam F, Boldorini R, et al. Distinct Anti-IFI16 and Anti-GP2 antibodies in inflammatory bowel disease and their variation with infliximab therapy. Inflammatory Bowel Dis 2016;22(12):2977-2987.
(38) Pignoloni B, Fionda C, Dell'Oste V, Luganini A, Cippitelli M, Zingoni A, et al. Distinct roles for human cytomegalovirus immediate early proteins IE1 and IE2 in the transcriptional regulation of MICA and PVR/CD155 expression. J Immunol 2016;197(10):4066-4078.
(39) Landolfo S, De Andrea M. Interferon α/β. Encyclopedia of Immunobiology; 2016. p. 485-493.
(40) Alunno A, Caneparo V, Bistoni O, Caterbi S, Terenzi R, Gariglio M, et al. Circulating Interferon-Inducible Protein IFI16 Correlates with Clinical and Serological Features in Rheumatoid Arthritis. Arthritis Care Res 2016;68(4):440-445.
(41) Biolatti M, Dell'Oste V, Pautasso S, Von Einem J, Marschall M, Plachter B, et al. Regulatory interaction between the cellular restriction factor IFI16 and viral pp65 (pUL83) modulates viral gene expression and IFI16 protein stability. J Virol 2016;90(18):8238-8250.
(42) Alunno A, Caneparo V, Carubbi F, Bistoni O, Caterbi S, Bartoloni E, et al. Interferon gamma-inducible protein 16 in primary Sjögren's syndrome: A novel player in disease pathogenesis? Arthritis Res Ther 2015;17(1).
(43) Landini MM, Borgogna C, Peretti A, Doorbar J, Griffin H, Mignone F, et al. Identification of the skin virome in a boy with widespread human papillomavirus-2-positive warts that completely regressed after administration of tetravalent human papillomavirus vaccine. Br J Dermatol 2015;173(2):597-600.
(44) Bawadekar M, De Andrea M, Gariglio M, Landolfo S. Mislocalization of the interferon inducible protein IFI16 by environmental insults: Implications in autoimmunity. Cytokine Growth Factor Rev 2015;26(2):213-219.
(45) Alunno A, Caneparo V, Carubbi F, Bistoni O, Caterbi S, Gariglio M, et al. Interferon gamma-inducible protein 16 (IFI16) and anti-IFI16 antibodies in primary Sjögren’s syndrome: Findings in serum and minor salivary glands. Reumatismo 2015;67(3):85-90.
(46) Cigno IL, de Andrea M, Borgogna C, Albertini S, Landini MM, Peretti A, et al. The nuclear DNA sensor IFI16 acts as a restriction factor for human papillomavirus replication through epigenetic modifications of the viral promoters. J Virol 2015;89(15):7506-7520.
(47) Piccaluga PP, Agostinelli C, Fuligni F, Righi S, Tripodo C, Re MC, et al. IFI16 expression is related to selected transcription factors during B-cell differentiation. J Immunol Res 2015;2015.
(48) Bawadekar M, De Andrea M, Lo Cigno I, Baldanzi G, Caneparo V, Graziani A, et al. The Extracellular IFI16 Protein Propagates Inflammation in Endothelial Cells Via p38 MAPK and NF-κB p65 Activation. J Interferon Cytokine Res 2015;35(6):441-453.
(49) Del Prete A, Luganini A, Scutera S, Rossi S, Anselmo A, Greco D, et al. Interferon-α production by plasmacytoid dendritic cells is dispensable for an effective anti-cytomegalovirus response in adaptor protein-3-deficient mice. J Interferon Cytokine Res 2015;35(3):232-238.
(50) Dell'Oste V, Gatti D, Giorgio AG, Gariglio M, Landolfo S, De Andrea M. The interferon-inducible DNA-sensor protein IFI16: A key player in the antiviral response. New Microbiol 2015;38(1):5-20.
(51) Peretti A, Borgogna C, Rossi D, De Paoli L, Bawadekar M, Zavattaro E, et al. Analysis of human β-papillomavirus and Merkel cell polyomavirus infection in skin lesions and eyebrow hair bulbs from a cohort of patients with chronic lymphocytic leukaemia. Br J Dermatol 2014;171(6):1525-1528.
(52) Lambert AJ, Huhtamo E, Di Fatta T, De Andrea M, Borella A, Vapalahti O, et al. Serological evidence of batai virus infections, Bovines, Northern Italy, 2011. Vector Borne Zoonotic Dis 2014;14(9):688-689.
(53) Borgogna C, Lanfredini S, Peretti A, De Andrea M, Zavattaro E, Colombo E, et al. Improved detection reveals active β-papillomavirus infection in skin lesions from kidney transplant recipients. Mod Pathol 2014;27(8):1101-1115.
(54) Landini MM, Borgogna C, Peretti A, Colombo E, Zavattaro E, Boldorini R, et al. α- and β-Papillomavirus infection in a young patient with an unclassified primary T-cell immunodeficiency and multiple mucosal and cutaneous lesions. J Am Acad Dermatol 2014;71(1):108-115.e1.
(55) Landolfo S, Andrea MD, Gariglio M. Restriction factors against human CMV. Future Virol 2014;9(5):499-511.
(56) Borgogna C, Lanfredini S, Peretti A, De Andrea M, Zavattaro E, Colombo E, et al. Erratum: Improved detection reveals active β-papillomavirus infection in skin lesions from kidney transplant recipients (Modern Pathology (2014) 27 (917) DOI:10.1038/modpathol.2014.2). Mod Pathol 2014;27(6):917.
(57) Dell'Oste V, Gatti D, Gugliesi F, De Andrea M, Bawadekar M, Cigno IL, et al. Innate nuclear sensor IFI16 translocates into the cytoplasm during the early stage of In vitro human cytomegalovirus infection and is entrapped in the egressing virions during the late stage. J Virol 2014;88(12):6970-6982.
(58) Mazibrada J, Longo L, Vatrano S, Cappia S, Giorcelli J, Pentenero M, et al. Differential expression of HER2, STAT3, SOX2, IFI16 and cell cycle markers during HPV-related head and neck carcinogenesis. New Microbiol 2014;37(2):129-143.
(59) Bon I, Lembo D, Rusnati M, Clò A, Morini S, Miserocchi A, et al. Peptide-Derivatized SB105-A10 Dendrimer Inhibits the Infectivity of R5 and X4 HIV-1 Strains in Primary PBMCs and Cervicovaginal Histocultures. PLoS ONE 2013;8(10).
(60) Gugliesi F, Bawadekar M, de Andrea M, Dell'Oste V, Caneparo V, Tincani A, et al. Nuclear DNA Sensor IFI16 as Circulating Protein in Autoimmune Diseases Is a Signal of Damage that Impairs Endothelial Cells through High-Affinity Membrane Binding. PLoS ONE 2013;8(5).
(61) Caneparo V, Cena T, De Andrea M, Dell'Oste V, Stratta P, Quaglia M, et al. Anti-IFI16 antibodies and their relation to disease characteristics in systemic lupus erythematosus. Lupus 2013;22(6):607-613.
(62) Rittà M, Landolfo V, Mazibrada J, De Andrea M, Dell'Oste V, Caneparo V, et al. Human papillomavirus tumor-infiltrating T-regulatory lymphocytes and P53 codon 72 polymorphisms correlate with clinical staging and prognosis of oropharyngeal cancer. New Microbiol 2013;36(2):133-144.
(63) Horan KA, Hansen K, Jakobsen MR, Holm CK, Søby S, Unterholzner L, et al. Proteasomal degradation of herpes simplex virus capsids in macrophages releases DNA to the cytosol for recognition by DNA sensors. J Immunol 2013;190(5):2311-2319.
(64) Dell'Oste V, Caneparo V, de Andrea M, Gariglio M, Landolfo S. IFI16 Autoantibodies. Autoantibodies: Third Edition; 2013. p. 333-340.
(65) Donalisio M, Rusnati M, Cagno V, Civra A, Bugatti A, Giuliani A, et al. Inhibition of human respiratory syncytial virus infectivity by a dendrimeric heparan sulfate-binding peptide. Antimicrob Agents Chemother 2012;56(10):5278-5288.
(66) Bronzini M, Luganini A, Dell'Oste V, De Andrea M, Landolfo S, Gribaudo G. The US16 gene of human cytomegalovirus is required for efficient viral infection of endothelial and epithelial cells. J Virol 2012;86(12):6875-6888.
(67) Rossini G, Cerboni C, Santoni A, Landini MP, Landolfo S, Gatti D, et al. Interplay between human cytomegalovirus and intrinsic/innate host responses: A complex bidirectional relationship. Mediators Inflamm 2012;2012.
(68) Borgogna C, Zavattaro E, De Andrea M, Griffin HM, Dell'Oste V, Azzimonti B, et al. Characterization of beta papillomavirus E4 expression in tumours from Epidermodysplasia Verruciformis patients and in experimental models. Virology 2012;423(2):195-204.
(69) Landini MM, Zavattaro E, Borgogna C, Azzimonti B, De Andrea M, Colombo E, et al. Lack of EVER2 protein in two epidermodysplasia verruciformis patients with skin cancer presenting previously unreported homozygous genetic deletions in the EVER2 gene. J Invest Dermatol 2012;132(4):1305-1308.
(70) Gariano GR, Dell'Oste V, Bronzini M, Gatti D, Luganini A, de Andrea M, et al. The intracellular DNA sensor IFI16 gene acts as restriction factor for human Cytomegalovirus replication. PLoS Pathog 2012;8(1).
(71) Gugliesi F, Dell'Oste V, De Andrea M, Baggetta R, Mondini M, Zannetti C, et al. Tumor-derived endothelial cells evade apoptotic activity of the interferon-inducible IFI16 gene. J Interferon Cytokine Res 2011;31(8):609-618.
(72) Luganini A, Nicoletto SF, Pizzuto L, Pirri G, Giuliani A, Landolfo S, et al. Inhibition of herpes simplex virus type 1 and type 2 infections by peptide-derivatized dendrimers. Antimicrob Agents Chemother 2011;55(7):3231-3239.
(73) Noris E, Poli A, Cojoca R, Rittà M, Cavallo F, Vaglio S, et al. A human papillomavirus 8 E7 protein produced in plants is able to trigger the mouse immune system and delay the development of skin lesions. Arch Virol 2011;156(4):587-595.
(74) Costa S, Mondini M, Caneparo V, Afeltra A, Airò P, Bellisai F, et al. Detection of anti-IFI16 antibodies by ELISA: Clinical and serological associations in systemic sclerosis. Rheumatology (UK) 2011;50(4):674-681.
(75) Fiorentini S, Luganini A, Dell'Oste V, Lorusso B, Cervi E, Caccuri F, et al. Human cytomegalovirus productively infects lymphatic endothelial cells and induces a secretome that promotes angiogenesis and lymphangiogenesis through interleukin-6 and granulocyte-macrophage colony-stimulating factor. J Gen Virol 2011;92(3):650-660.
(76) Costa S, Borgogna C, Mondini M, De Andrea M, Meroni PL, Berti E, et al. Redistribution of the nuclear protein IFI16 into the cytoplasm of ultraviolet B-exposed keratinocytes as a mechanism of autoantigen processing. Br J Dermatol 2011;164(2):282-290.
(77) Gariglio M, Mondini M, De Andrea M, Landolfo S. The multifaceted interferon-inducible p200 family proteins: From cell biology to human pathology. J Interferon Cytokine Res 2011;31(1):159-172.
(78) De Andrea M, Rittà M, Landini MM, Borgogna C, Mondini M, Kern F, et al. Keratinocyte-specific stat3 heterozygosity impairs development of skin tumors in human papillomavirus 8 transgenic mice. Cancer Res 2010;70(20):7938-7948.
(79) Donalisio M, Rusnati M, Civra A, Bugatti A, Allemand D, Pirri G, et al. Identification of a dendrimeric heparan sulfate-binding peptide that inhibits infectivity of genital types of human papillomaviruses. Antimicrob Agents Chemother 2010;54(10):4290-4299.
(80) Gugliesi F, De Andrea M, Mondini M, Cappello P, Giovarelli M, Shoenfeld Y, et al. The proapoptotic activity of the Interferon-inducible gene IFI16 provides new insights into its etiopathogenetic role in autoimmunity. J Autoimmun 2010;35(2):114-123.
(81) Baggetta R, De Andrea M, Gariano GR, Mondini M, Rittà M, Caposio P, et al. The interferon-inducible gene IFI16 secretome of endothelial cells drives the early steps of the inflammatory response. Eur J Immunol 2010;40(8):2182-2189.
(82) Mondini M, Costa S, Sponza S, Gugliesi F, Gariglio M, Landolfo S. The interferon-inducible HIN-200 gene family in apoptosis and inflammation: Implication for autoimmunity. Autoimmunity 2010;43(3):226-231.
(83) Caposio P, Luganini A, Bronzini M, Landolfo S, Gribaudo G. The Elk-1 and serum response factor binding sites in the major immediate-early promoter of human cytomegalovirus are required for efficient viral replication in quiescent cells and compensate for inactivation of the NF-κB sites in proliferating cells. J Virol 2010;84(9):4481-4493.
(84) Donalisio M, Poli A, Civra A, Landolfo S, Lembo D. Effects of cytokines on long control region transcriptional activity in high-risk cutaneous human papillomavirus types 5 and 8. Arch Virol 2010;155(4):583-587.
(85) Foglio-Bonda P-, Gabriele M, Graziani F, De Andrea M, Mondini M, Gariglio M. High prevalence of human cytomegalovirus in a population of periodontally healthy subjects. Med Oral Patol Oral Cir Bucal 2010;15(2):e292-e296.
(86) Luganini A, Giuliani A, Pirri G, Pizzuto L, Landolfo S, Gribaudo G. Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate. Antiviral Res 2010;85(3):532-540.
(87) Mazibrada J, Andrea MD, Rittà M, Borgogna C, dell'Eva R, Pfeffer U, et al. In vivo growth inhibition of head and neck squamous cell carcinoma by the Interferon-inducible gene IFI16. Cancer Lett 2010;287(1):33-43.
(88) Paoletti T, Fallarini S, Gugliesi F, Minassi A, Appendino G, Lombardi G. Anti-inflammatory and vascularprotective properties of 8-prenylapigenin. Eur J Pharmacol 2009;620(1-3):120-130.
(89) Borgogna C, Zavattaro E, Dell'Oste V, Mondini M, Valente G, Colombo E, et al. No indications for HPV involvement in the hypertrophic skin lesions of a Darier disease case without ATP2A2 gene mutations. J Cutaneous Pathol 2009;36(9):1005-1009.
(90) Rusnati M, Vicenzi E, Donalisio M, Oreste P, Landolfo S, Lembo D. Sulfated K5 Escherichia coli polysaccharide derivatives: A novel class of candidate antiviral microbicides. Pharmacol Ther 2009;123(3):310-322.
(91) Azzimonti B, Dell'Oste V, Borgogna C, Mondini M, Gugliesi F, De Andrea M, et al. The epithelial-mesenchymal transition induced by keratinocyte growth conditions is overcome by E6 and E7 from HPV16, but not HPV8 and HPV38: Characterization of global transcription profiles. Virology 2009;388(2):260-269.
(92) Borgogna C, Toniutto P, Smirne C, Azzimonti B, Rittà M, Avellini C, et al. Expression of the interferon-inducible proteins MxA and IFI16 in liver allografts. Histopathology 2009;54(7):837-846.
(93) Sponza S, De Andrea M, Mondini M, Gugliesi F, Gariglio M, Landolfo S. Role of the interferon-inducible IFI16 gene in the induction of ICAM-1 by TNF-α. Cell Immunol 2009;257(1-2):55-60.
(94) Rittà M, De Andrea M, Mondini M, Mazibrada J, Giordano C, Pecorari G, et al. Cell cycle and viral and immunologic profiles of head and neck squamous cell carcinoma as predictable variables of tumor progression. Head Neck 2009;31(3):318-327.
(95) Dell'Oste V, Azzimonti B, De Andrea M, Mondini M, Zavattaro E, Leigheb G, et al. High β-HPV DNA loads and strong seroreactivity are present in epidermodysplasia verruciformis. J Invest Dermatol 2009;129(4):1026-1034.
(96) Luganini A, Caposio P, Mondini M, Landolfo S, Gribaudo G. New cell-based indicator assays for the detection of human cytomegalovirus infection and screening of inhibitors of viral immediate-early 2 protein activity. J Appl Microbiol 2008;105(6):1791-1801.
(97) Dell'Oste V, Azzimonti B, Mondini M, de Andrea M, Borgogna C, Mesturini R, et al. Altered expression of UVB-induced cytokines in human papillomavirus-immortalized epithelial cells. J Gen Virol 2008;89(10):2461-2466.
(98) Funaro A, Gribaudo G, Luganini A, Ortolan E, Lo Buono N, Vicenzi E, et al. Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells. BMC Biotechnol 2008;8.
(99) Mazibrada J, Rittà M, Mondini M, De Andrea M, Azzimonti B, Borgogna C, et al. Corrigendum to "Interaction between inflammation and angiogenesis during different stages of cervical carcinogenesis" [Gynecol. Oncol. 108 (2008) 112-120] (DOI:10.1016/j.ygyno.2007.08.095). Gynecol Oncol 2008;110(1):118.
(100) Lembo D, Donalisio M, Rusnati M, Bugatti A, Cornaglia M, Cappello P, et al. Sulfated K5 Escherichia coli polysaccharide derivatives as wide-range inhibitors of genital types of human papillomavirus. Antimicrob Agents Chemother 2008;52(4):1374-1381.
(101) Luganini A, Caposio P, Landolfo S, Gribaudo G. Phosphorothioate-modified oligodeoxynucleotides inhibit human cytomegalovirus replication by blocking virus entry. Antimicrob Agents Chemother 2008;52(3):1111-1120.
(102) Donalisio M, Cornaglia M, Landolfo S, Lembo D. TGF-β1 and IL-4 downregulate human papillomavirus-16 oncogene expression but have differential effects on the malignant phenotype of cervical carcinoma cells. Virus Res 2008;132(1-2):253-256.
(103) Zavattaro E, Azzimonti B, Mondini M, De Andrea M, Borgogna C, Dell'Oste V, et al. Identification of defective Fas function and variation of the perforin gene in an epidermodysplasia verruciformis patient lacking EVER1 and EVER2 mutations [3]. J Invest Dermatol 2008;128(3):732-735.
(104) Mazibrada J, Rittà M, Mondini M, De Andrea M, Azzimonti B, Borgogna C, et al. Interaction between inflammation and angiogenesis during different stages of cervical carcinogenesis. Gynecol Oncol 2008;108(1):112-120.
(105) Riboldi P, Gerosa M, Mondini M, Landolfo S. Interferon-inducible protein IFI16 autoantibodies. Autoantibodies; 2007. p. 331-337.
(106) Caposio P, Gugliesi F, Zannetti C, Sponza S, Mondini M, Medico E, et al. A novel role of the interferon-inducible protein IFI16 as inducer of proinflammatory molecules in endothelial cells. J Biol Chem 2007;282(46):33515-33529.
(107) De Andrea M, Gioia D, Mondini M, Azzimonti B, Renò F, Pecorari G, et al. Effects of IFI16 overexpression on the growth and doxorubicin sensitivity of head and neck squamous cell carcinoma-derived cell lines. Head Neck 2007;29(9):835-844.
(108) Caposio P, Luganini A, Hahn G, Landolfo S, Gribaudo G. Activation of the virus-induced IKK/NF-κB signalling axis is critical for the replication of human cytomegalovirus in quiescent cells. Cell Microbiol 2007;9(8):2040-2054.
(109) Caposio P, Musso T, Luganini A, Inoue H, Gariglio M, Landolfo S, et al. Targeting the NF-κB pathway through pharmacological inhibition of IKK2 prevents human cytomegalovirus replication and virus-induced inflammatory response in infected endothelial cells. Antiviral Res 2007;73(3):175-184.
(110) De Andrea M, Mondini M, Azzimonti B, Dell'Oste V, Germano S, Gaudino G, et al. Alpha- and betapapillomavirus E6/E7 genes differentially modulate pro-inflammatory gene expression. Virus Res 2007;124(1-2):220-225.
(111) Mondini M, Vidali M, Airò P, De Andrea M, Riboldi P, Meroni PL, et al. Role of the interferon-inducible gene IFI16 in the etiopathogenesis of systemic autoimmune disorders. Ann New York Acad Sci 2007;1110:47-56.
(112) Mondini M, Vidali M, De Andrea M, Azzimonti B, Airò P, D'Ambrosio R, et al. A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: The interferon-inducible gene IFI16. Arthritis Rheum 2006;54(12):3939-3944.
(113) Lembo D, Donalisio M, Cornaglia M, Azzimonti B, Demurtas A, Landolfo S. Effect of high-risk human papillomavirus oncoproteins on p53R2 gene expression after DNA damage. Virus Res 2006;122(1-2):189-193.
(114) Zannetti C, Mondini M, De Andrea M, Caposio P, Hara E, Peters G, et al. The expression of p16INK4a tumor suppressor is upregulated by human cytomegalovirus infection and required for optimal viral replication. Virology 2006;349(1):79-86.
(115) De Petrini M, Rittà M, Schena M, Chiusa L, Campisi P, Giordano C, et al. Head and neck squamous cell carcinoma: Role of the human papillomavirus in tumour progression. New Microbiol 2006;29(1):25-33.
(116) Drosera M, Facchetti F, Landolfo S, Mondini M, Nyberg F, Parodi A, et al. Role of soluble and cell surface molecules in the pathogenesis of autoimmune skin diseases. Clin Exp Rheumatol 2006;24(SUPPL. 40):S7-S13.
(117) Lembo D, Donalisio M, De Andrea M, Cornaglia M, Scutera S, Musso T, et al. A cell-based high-throughput assay for screening inhibitors of human papillomavirus-16 long control region activity. FASEB J 2006;20(1):148-150.
(118) Azzimonti B, Mondini M, De Andrea M, Gioia D, Dianzani U, Mesturini R, et al. CD8+ T-cell lymphocytopenia and lack of EVER mutations in a patient with clinically and virologically typical epidermodysplasia verruciformis. Arch Dermatol 2005;141(10):1323-1325.
(119) Gugliesi F, Mondini M, Ravera R, Robotti A, De Andrea M, Gribaudo G, et al. Up-regulation of the interferon-inducible IFI16 gene by oxidative stress triggers p53 transcriptional activity in endothelial cells. J Leukocyte Biol 2005;77(5):820-829.
(120) Azzimonti B, Pagano M, Mondini M, De Andrea M, Valente G, Monga G, et al. Altered patterns of the interferon-inducible gene IFI16 expression in head and neck squamous cell carcinoma: Immunohistochemical study including correlation with retinoblastoma protein, human papillomavirus infection and proliferation index. Histopathology 2004;45(6):560-572.
(121) Caposio P, Riera L, Hahn G, Landolfo S, Gribaudo G. Evidence that the Human Cytomegalovirus 46-kDa UL72 protein is not an active dUTPase but a late protein dispensable for replication in fibroblasts. Virology 2004;325(2):264-276.
(122) Fineschi S, Borghi MO, Riboldi P, Gariglio M, Buzio C, Landolfo S, et al. Prevalence of autoantibodies against structure specific recognition protein 1 in systemic lupus erythematosus. Lupus 2004;13(6):463-468.
(123) Caposio P, Dreano M, Garotta G, Gribaudo G, Landolfo S. Human Cytomegalovirus Stimulates Cellular IKK2 Activity and Requires the Enzyme for Productive Replication. J Virol 2004;78(6):3190-3195.
(124) Raffaella R, Gioia D, De Andrea M, Cappello P, Giovarelli M, Marconi P, et al. The interferon-inducible IFI16 gene inhibits tube morphogenesis and proliferation of primary, but not HPV16 E6/E7-immortalized human endothelial cells. Exp Cell Res 2004;293(2):331-345.
(125) Lembo D, Donalisio M, Hofer A, Cornaglia M, Brune W, Koszinowski U, et al. The Ribonucleotide Reductase R1 Homolog of Murine Cytomegalovirus Is Not a Functional Enzyme Subunit but Is Required for Pathogenesis? J Virol 2004;78(8):4278-4288.
(126) Azzimonti B, De Andrea M, Valente G, Landolfo S, Gariglio M. An analysis of the role of papillomavirus in precancerous lesions of the larynx. Ig Mod 2003;119(2):89-94.
(127) De Andrea M, Gioia D, Azzimonti B, Noris E, Landolfo S, Gariglio M. Biological properties and genomic organization of the family of Interferon-inducible murine Ifi 200 and its human counterpart HIN200. Ig Mod 2003;119(3):135-145.
(128) Buttiglieri S, Galetto A, Forno S, De Andrea M, Matera L. Influence of drug-induced apoptotic death on processing and presentation of tumor antigens by dendritic cells. Int J Cancer 2003;106(4):516-520.
(129) Landolfo S, Gariglio M, Gribaudo G, Lembo D. The human cytomegalovirus. Pharmacol Ther 2003;98(3):269-297.
(130) Gribaudo G, Riera L, Caposio P, Maley F, Landolfo S. Human cytomegalovirus requires cellular deoxycytidylate deaminase for replication in quiescent cells. J Gen Virol 2003;84(6):1437-1441.
(131) De Andrea M, Zannetti C, Noris E, Gariglio M, Azzimonti B, Landolfo S. The mouse interferon-inducible gene Ifi204 product interacts with the Tpr protein, a component of the nuclear pore complex. J Interferon Cytokine Res 2002;22(11):1113-1121.
(132) Gribaudo G, Riera L, Rudge TL, Caposio P, Johnson LF, Landolfo S. Human cytomegalovirus infection induces cellular thymidylate synthase gene expression in quiescent fibroblasts. J Gen Virol 2002;83(12):2983-2993.
(133) Noris E, Zannetti C, Demurtas A, Sinclair J, De Andrea M, Gariglio M, et al. Cell cycle arrest by human cytomegalovirus 86-kDa IE2 protein resembles premature senescence. J Virol 2002;76(23):12135-12148.
(134) Gariglio M, Azzimonti B, Pagano M, Palestro G, De Andrea M, Valente G, et al. Immunohistochemical expression analysis of the human interferon-inducible gene IFI16, a member of the HIN200 family, not restricted to hematopoietic cells. J Interferon Cytokine Res 2002;22(7):815-821.
(135) De Andrea M, Ravotto M, Noris E, Ying G-, Gioia D, Azzimonti B, et al. The interferon-inducible gene, Ifi204, acquires malignant transformation capability upon mutation at the Rb-binding sites. FEBS Lett 2002;515(1-3):51-57.
(136) Caposio P, Pessione E, Giuffrida G, Conti A, Landolfo S, Giunta C, et al. Cloning and characterization of two catechol 1,2-dioxygenase genes from Acinetobacter radioresistens S13. Res Microbiol 2002;153(2):69-74.
(137) Santoro P, De Andrea M, Migliaretti G, Trapani C, Landolfo S, Gariglio M. High prevalence of autoantibodies against the nuclear high mobility group (HMG) protein SSRP1 in sera from patients with systemic lupus erythematosus, but not other rheumatic diseases. J Rheumatol 2002;29(1):90-93.
(138) De Andrea M, Ravera R, Gioia D, Gariglio M, Landolfo S. The interferon system: An overview. Eur J Paediatr Neurol 2002;6(SUPPL. 1):A41-A46.
(139) Zanon C, Clara R, Bortolini M, Malossi A, Moscato R, Celoria P, et al. Chemohyperthermia for advanced abdominal malignancies: A new procedure with closed abdomen and previously performed anastomosis. Int J Hyperthermia 2001;17(5):456-464.
(140) Pessione E, Giuffrida MG, Mazzoli R, Caposio P, Landolfo S, Conti A, et al. The catechol 1,2 dioxygenase system of Acinetobacter radioresistens: Isoenzymes, inductors and gene localisation. Biol Chem 2001;382(8):1253-1261.
(141) Cavallo R, Lembo D, Gribaudo G, Landolfo S. Murine cytomegalovirus infection induces cellular folylpolyglutamate synthetase activity in quiescent cells. Intervirology 2001;44(4):224-226.
(142) Rolle S, De Andrea M, Gioia D, Lembo D, Hertel L, Landolfo S, et al. The interferon-inducible 204 gene is transcriptionally activated by mouse cytomegalovirus and is required for its replication. Virology 2001;286(2):249-255.
(143) Riera L, Gariglio M, Pagano M, Gaiola O, Simon MM, Landolfo S. Control of murine cytomegalovirus replication in salivary glands during acute infection is independent of the fas ligand/fas system. New Microbiol 2001;24(3):231-238.
(144) Gribaudo G, Riera L, Lembo D, De Andrea M, Johnson LF, Landolfo S. The anticytomegaloviral activity of raltitrexed is abrogated in quiescent mouse fibroblasts that overexpress thymidylate synthase. Virus Res 2001;73(1):57-65.
(145) Lembo D, Gribaudo G, Hofer A, Riera L, Cornaglia M, Mondo A, et al. Expression of an altered ribonucleotide reductase activity associated with the replication of murine cytomegalovirus in quiescent fibroblasts. J Virol 2000;74(24):11557-11565.
(146) Lembo D, Gribaudo G, Riera L, Mondo A, Cavallo R, Angeretti A, et al. The thymidylate synthase inhibitor ZD1694 potently inhibits murine and human cytomegalovirus replication in quiescent fibroblasts. Antiviral Res 2000;47(2):111-120.
(147) Hertel L, Rolle S, De Andrea M, Azzimonti B, Osello R, Gribaudo G, et al. The retinoblastoma protein is an essential mediator that links the interferon-inducible 204 gene to cell-cycle regulation. Oncogene 2000;19(32):3598-3608.
(148) Riera L, Gariglio M, Valente G, Müllbacher A, Museteanu C, Landolfo S, et al. Murine cytomegalovirus replication in salivary glands is controlled by both perforin and granzymes during acute infection. Eur J Immunol 2000;30(5):1350-1355.
(149) Gribaudo G, Riera L, Lembo D, De Andrea M, Gariglio M, Rudge TL, et al. Murine cytomegalovirus stimulates cellular thymidylate synthase gene expression in quiescent cells and requires the enzyme for replication. J Virol 2000;74(11):4979-4987.
(150) Landolfo S, Guarini A, Riera L, Gariglio M, Gribaudo G, Cignetti A, et al. Chronic myeloid leukemia cells resistant to interferon-α lack STAT1 expression. Hematol J 2000;1(1):7-14.
(151) Brancaccio M, Guazzone S, Menini N, Sibona E, Hirsch E, De Andrea M, et al. Melusin is a new muscle-specific interactor for β1 integrin cytoplasmic domain. J Biol Chem 1999;274(41):29282-29288.
(152) Hertel L, De Andrea M, Azzimonti B, Rolle A, Gariglio M, Landolfo S. The interferon-inducible 204 gene, a member of the lfi 200 family, is not involved in the antiviral state induction by IFN-α, but is required by the mouse cytomegalovirus for its replication. Virology 1999;262(1):1-8.
(153) Lembo D, Cavallo R, Cornaglia M, Mondo A, Hertel L, Angeretti A, et al. Overexpression of cellular dihydrofolate reductase abolishes the anticytomegaloviral activity of methotrexate. Arch Virol 1999;144(7):1397-1403.
(154) Azzimonti B, Hertel L, Aluffi P, Francesco P, Monga G, Zocchi M, et al. Demonstration of multiple HPV types in laryngeal premalignant lesions using polymerase chain reaction and immunohistochemistry. J Med Virol 1999;59(1):110-116.
(155) Hertel L, De Andrea M, Bellomo G, Santoro P, Landolfo S, Gariglio M. The HMG protein T160 colocalizes with DNA replication foci and is down- regulated during cell differentiation. Exp Cell Res 1999;250(2):313-328.
(156) Gribaudo G, Riera L, De Andrea M, Landolfo S. The antiproliferative activity of the murine interferon-inducible Ifi 200 proteins depends on the presence of two 200 amino acid domains. FEBS Lett 1999;456(1):31-36.
(157) Lembo D, Gribaudo G, Cavallo R, Riera L, Angeretti A, Hertel L, et al. Human cytomegalovirus stimulates cellular dihydrofolate reductase activity in quiescent cells. Intervirology 1999;42(1):30-36.
(158) Gribaudo G, Riera L, Hertel L, Landolfo S. In vitro and in vivo expression analysis of the interferon-inducible 203 gene. J Interferon Cytokine Res 1999;19(2):129-136.
(159) Tarozzo G, Cappello P, De Andrea M, Walters E, Margolis L, Oestreicher B, et al. Prenatal differentiation of mouse vomeronasal neurones. Eur J Neurosci 1998;10(1):392-396.
(160) Tarozzo G, De Andrea M, Feuilloley M, Vaudry H, Fasolo A. Molecular and cellular guidance of neuronal migration in the developing olfactory system of rodents. Ann New York Acad Sci 1998;839:196-200.
(161) Lembo M, Sacchi C, Zappador C, Bellomo G, Gaboli M, Pandolfi PP, et al. Inhibition of cell proliferation by the interferon-inducible 204 gene, a member of the Ifi 200 cluster. Oncogene 1998;16(12):1543-1551.
(162) Landolfo S, Gariglio M, Gribaudo G, Lembo D. The Ifi 200 genes: An emerging family of IFN-inducible genes. Biochimie 1998;80(8-9):721-728.
(163) Gariglio M, De Andrea M, Lembo M, Ravotto M, Zappador C, Valente G, et al. The murine homolog of the HIN 200 family, Ifi 204, is constitutively expressed in myeloid cells and selectively induced in the monocyte/macrophage lineage. J Leukocyte Biol 1998;64(5):608-614.
(164) Lembo D, Angeretti A, Gariglio M, Landolfo S. Murine cytomegalovirus induces expression and enzyme activity of cellular dihydrofolate reductase in quiescent cells. J Gen Virol 1998;79(11):2803-2807.
(165) Landolfo S, Gariglio M, Gribaudo G. The interferon inducible proteins as mediators of their biological activities. Rev Clin Exp Hematol 1998(6):21-35.
(166) Gariglio M, Ying G-, Hertel L, Gaboli M, Clerc RG, Landolfo S. The high-mobility group protein T160 binds to both linear and cruciform DNA and mediates DNA bending as determined by ring closure. Exp Cell Res 1997;236(2):472-481.
(167) Hertel L, Foresta P, Barbiero G, Ying GG, Bonelli G, Baccino FM, et al. Decreased expression of the high-mobility group protein T160 by antisense RNA impairs the growth of mouse fibroblasts. Biochimie 1997;79(12):717-723.
(168) Gariglio M, Foresta P, Sacchi C, Lembo M, Hertel L, Landolfo S. Suppression of high mobility group protein T160 expression impairs mouse cytomegalovirus replication. J Gen Virol 1997;78(3):665-670.
(169) Gribaudo G, Ravaglia S, Guandalini L, Riera L, Gariglio M, Landolfo S. Molecular cloning and expression of an interferon-inducible protein encoded by gene 203 from the gene 200 cluster. Eur J Biochem 1997;249(1):258-264.
(170) Lembo D, Ricciardi-Castagnoli P, Alber G, Ozmen L, Landolfo S, Blüthmann H, et al. Mouse macrophages carrying both subunits of the human interferon-γ (IFN-γ) receptor respond to human IFN-γ but do not acquire full protection against viral cytopathic effect. J Biol Chem 1996;271(51):32659-32666.
(171) Gribaudo G, Ravaglia S, Guandalini L, Cavallo R, Gariglio M, Landolfo S. The murine cytomegalovirus immediate-early 1 protein stimulates NF-κB activity by transactivating the NF-κB p105/p50 promoter. Virus Res 1996;45(1):15-27.
(172) Lanzi G, Fazzi E, Veggiotti P, Pagliano E, Gariglio M, Bonaglia C, et al. Ring chromosome 9: An atypical case. BRAIN DEVELOP 1996;18(3):216-219.
(173) Landolfo S, Angeretti A, Gariglio M, Gribaudo G, Lembo D. The interferon system in resistance against viral infections. Ig Mod 1995;104(4):543-554.
(174) Gribaudo G, Ravaglia S, Gaboli M, Gariglio M, Cavallo R, Landolfo S. Interferon-α Inhibits the Murine Cytomegalovirus Immediate-Early Gene Expression by Down-Regulating NF-κB Activity. Virology 1995;211(1):251-260.
(175) Lembo D, Angeretti A, Benefazio S, Hertel L, Gariglio M, Novelli F, et al. Constitutive expression of the interferon-inducible protein p202 in NIH 3T3 cells affects cell cycle progression. J BIOL REGUL HOMEOSTATIC AGENTS 1995;9(2):42-46.
(176) Lembo D, Angeretti A, Gaboli M, Cavallo R, Landolfo S. Modulation of HIV-LTR activity by ras oncogenes. New Microbiol 1995;18(2):111-116.
(177) Landolfo S, Gribaudo G, Angeretti A, Gariglio M. Mechanisms of viral inhibition by interferons. Pharmacol Ther 1995;65(3):415-442.
(178) Gaboli M, Angeretti A, Lembo D, Gariglio M, Gribaudo G, Landolfo S. cAMP response element of murine cytomegalovirus immediate early gene enhancer is transactivated by ras oncogene products. J Gen Virol 1995;76(4):751-758.
(179) GARIGLIO M, GABOLI M, MANA C, YING G‐, GRIBAUDO G, CAVALLO R, et al. Characterization of nuclear factors involved in 202 gene induction by interferon‐α in murine leukemia cells. Eur J Biochem 1994;221(2):731-739.
(180) Gariglio M, Gaboli M, Mana C, Foresta P, Ying GG, Angeretti A, et al. Characterization of nuclear factors involved in 202 gene induction by IFN-alpha, viruses or dsRNA in murine leukemia cells. New Microbiol 1994;17(4):259-267.
(181) Cavallo R, Valente G, Jemma C, Gribaudo G, Landolfo S, Cavallo G. Presence of murine retroviral sequences in human cell line transplanted in immunosuppressed SCID-mice. New Microbiol 1994;17(3):195-202.
(182) Gribaudo G, Landolfo S, Cavallo G. Viral evasion of cytokine-mediated host defense mechanisms. G Batteriol Virol Immunol 1994;86(1-12):3-10.
(183) Lembo D, Angeretti A, Cavallo R, Gariglio M, Gribaudo G, Landolfo S. Protein p53 inhibits the activity of the enhancer of the immediate-early genes of murine cytomegalovirus. G Batteriol Virol Immunol 1994;86(1-12):43-54.
(184) Angeretti A, Lembo D, Cavallo R, Gariglio M, Gribaudo G, Landolfo S. Serum stimulates the transcriptional activity of the enhancer of the immediate-early genes of the murine cytomegalovirus through p21 ras. G Batteriol Virol Immunol 1994;86(1-12):55-64.
(185) Lembo D, Angeretti A, Foresta P, Gribaudo G, Gariglio M, Landolfo S. Trans-activation of the mouse cytomegalovirus immediate early gene enhancer by ras oncogenes. J Gen Virol 1994;75(7):1685-1692.
(186) Landolfo S, Gariglio M, Gribaudo G, Garotta G. Double-stranded RNAs as gene activators. Prog Mol Subcell Biol 1994;14:15-27.
(187) Martinotti MG, Gribaudo G, Gariglio M, Caliendo A, Lembo D, Angeretti A, et al. Effect of Interferon-α on Immediate Early Gene Expression of Murine Cytomegalovirus. J Interferon Res 1993;13(2):105-109.
(188) Gribaudo G, Bavaglia S, Caliendo A, Cavallo R, Gariglio M, Martinotti MG, et al. Interferons inhibit onset of murine cytomegalovirus immediate-early gene transcription. Virology 1993;197(1):303-311.
(189) Caruso A, Tiberio L, De Rango C, Bonfanti C, Flamminio G, Gribaudo G, et al. A monoclonal antibody to the NH2-terminal segment of human IFN-γ selectively interferes with the antiproliferative activity of the lymphokine. J Immunol 1993;150(3):1029-1035.
(190) Ozmen L, Gribaudo G, Fountoulakis M, Gentz R, Landolfo S, Garotta G. Mouse soluble IFNγ receptor as IFNγ inhibitor: Distribution, antigenicity, and activity after injection in mice. J Immunol 1993;150(7):2698-2705.
(191) Gribaudo G, Caliendo A, Lembo D, Cavallo R, Landolfo S. Molecular cloning of interferon-γ inducible genes from a murine pre-B cell leukemia. J BIOL REGUL HOMEOSTATIC AGENTS 1992;6(4):137-141.
(192) Lembo D, Gaboli M, Caliendo A, Falciani F, Garattini E, Landolfo S. Regulation of the 202 gene expression by interferons in L929 cells. Biochem Biophys Res Commun 1992;187(2):628-634.
(193) Caruso A, Viani E, Tiberio L, Pollara P, Monti E, Bonfanti C, et al. Inhibition of the Biological Activity of Human Interferon-γ by Antipeptide Antibodies. J Interferon Res 1992;12(1):49-54.
(194) Martinotti MG, Gribaudo G, Gariglio M, Angeretti A, Cavallo G, Landolfo S. Effects of interferon alpha on murine cytomegalovirus replication. Microbiologica 1992;15(2):183-186.
(195) Lembo D, Cofano F, Cavallo G, Landolfo S. The murine IFN-gamma receptor does not transduce the activation signal to a murine promoter in human cells. J BIOL REGUL HOMEOSTATIC AGENTS 1992;6(1):26-30.
(196) Nicoletti F, Meroni P, Di Marco R, Barcellini W, Borghi MO, Gariglio M, et al. In vivo treatment with a monoclonal antibody to interferon-gamma neither affects the survival nor the incidence of lupus-nephritis in the MRL/lpr-lpr mouse. Immunopharmacology 1992;24(1):11-16.
(197) Garotta G, Gribaudo G, Landolfo S, Ozmen L, Fountoulakis M, Stuber D, et al. The mouse soluble IFNγ receptor used in vivo as a possible immunomodulatory drug. MEDITERR J INFECT PARASIT DIS 1992;7(2):163-164.
(198) Landolfo S, Gariglio M, Gaboli M, Lembo D, Macario M, Cavallo R. Interferons as gene activators: Regulation at transcriptional level. MEDITERR J INFECT PARASIT DIS 1992;7(2):165-166.
(199) Turano A, Balsari A, Viani E, Landolfo S, Zanoni L, Gargiulo F, et al. Natural human antibodies to γ interferon interfere with the immunomodulating activity of the lymphokine. Proc Natl Acad Sci U S A 1992;89(10):4447-4451.
(200) Gariglio M, Panico S, Cavallo G, Divaker C, Lengyel P, Landolfo S. Impaired transcription of the poly rl:rC- and interferon-activatable 202 gene in mice and cell lines from the C57BU6 strain. Virology 1992;187(1):115-123.
(201) Gariglio G, Panico S, Gribaudo G, Martinotti MG, Cavallo G, Landolfo S. Characterization of the nuclear factors involved in 202 gene induction by IFN-alpha and NIH-3T3 cells. J BIOL REGUL HOMEOSTATIC AGENTS 1991;5(3):107-111.
(202) Khanna KK, An S, Wu JM, Landolfo S, Hovanessian AG. Absence of the 40-kDa form of (2'-5')oligoadenylate synthetase and its corresponding mRNA from skin fibroblasts derived from Alzheimer disease patients. Proc Natl Acad Sci U S A 1991;88(13):5852-5856.
(203) Gariglio M, Panico S, Gribaudo G, Martinotti MG, Cavallo G, Landolfo S. Activation of interferon-inducible genes in vivo by synthetic double-stranded RNA, poly rI:rC. Microbiologica 1991;14(3):179-183.
(204) Gariglio M, Martinotti MG, Cavallo G, Landolfo S. In-vitro interaction of cephalosporin and the immune system. J Chemother 1991;3 Suppl 1:128-130.
(205) Gribaudo G, Lembo D, Cavallo G, Landolfo S, Lengyel P. Interferon action: binding of viral RNA to the 40-kilodalton 2'-5'-oligoadenylate synthetase in interferon-treated HeLa cells infected with encephalomyocarditis virus. J Virol 1991;65(4):1748-1757.
(206) Altmeyer A, Staruch MJ, Cofano F, Landolfo S, Dumont FJ. Multiple cytokine interactions regulate Ly-6E antigen expression: Cooperative Ly-6E induction by IFNs, TNF, and IL-1 in a T cell lymphoma and in its induction-deficient variants. Cell Immunol 1991;138(1):94-107.
(207) Gariglio M, Cinato E, Panico S, Cavallo G, Landolfo S. Activation of interferon-inducible genes in mice by poly rI: Rc or alloantigens. J Immunother 1991;10(1):20-27.
(208) Nicoletti F, Luigi Meroni P, Landolfo S, Gariglio M, Guzzardi S, Barcellini W, et al. Prevention of diabetes in BB/Wor rats treated with monoclonal antibodies to interferon-γ. Lancet 1990;336(8710):319.
(209) Cofano F, Moore SK, Tanaka S, Yuhki N, Landolfo S, Appella E. Affinity purification, peptide analysis, and cDNA sequence of the mouse interferon γ receptor. J Biol Chem 1990;265(7):4064-4071.
(210) Cavallo G, Gariglio M, Panico S, Landolfo S. Regolazione delľ espressione genica in vivo da parte degli interferoni. Rend Fis Acc Lincei 1990;1(1):105-109.
(211) Gribaudo G, Franco A, Lembo D, Cavallo G, Landolfo S. The interferon system and interferon receptor binding. Haematologica 1990;75 Suppl 4:3-9.
(212) Martinotti MG, Gariglio M, Cofano F, Cavallo G, Landolfo S. The role of interferons in the resistance to murine cytomegalovirus. Microbiologica 1990;13(4):305-309.
(213) Gribaudo G, Gariglio M, Cavallo G, Landolfo S. Cell and type specificity of interferon action. Unusual characteristics of the transcriptional control of gene expression by interferon‐γ in T cells*. Eur J Immunol 1990;20(6):1243-1249.
(214) Caruso A, Bonfanti C, Colombrita D, De Francesco M, De Rango C, Foresti I, et al. Natural antibodies to IFN-γ in man and their increase during viral infection. J Immunol 1990;144(2):685-690.
(215) Gariglio M, Martinotti MG, Cavallo G, Landolfo S. Regulation of gene expression by interferons. G Batteriol Virol Immunol 1990;83(1-12):143-149.
(216) Gariglio M, Gribaudo G, Franco A, Pierotti MA, Cavallo G, Landolfo S. Inhibition of interferon-γ antiviral and antiproliferative activities by ras oncogene expression. J Natl Cancer Inst 1989;81(13):1014-1020.
(217) Cofano F, Landolfo S, Appella E, Ullrich SJ. Analysis of murine interferon-γ binding to its receptor on intact cells and solubilized membranes Identification of an 80 kDa receptor. FEBS Lett 1989;242(2):233-236.
(218) Landolfo S, Gribaudo G, Gariglio M, Fassio A, Franco A, Fizzotti M, et al. Differential control of T cell functions by IFN-alpha/beta and IFN-gamma. J Chemother 1989;1(4 Suppl):461-462.
(219) Gribaudo G, Fizzotti M, Cocciolo MG, Cavallo G, Landolfo S. Different mechanisms regulate the IFN-inducible expression of 40 kDA human 2'-5' oligo (A) synthetase in HeLa and Molt 4 cells. Int J Biol Markers 1989;4(4):221-225.
(220) Gariglio M, Cavallo G, Landolfo S. Retroviruses and cellular oncogenes. Int J Biol Markers 1989;4(4):233-236.
(221) Franco A, Fizzotti M, Gariglio M, Gribaudo G, Cavallo G, Landolfo S. Characterization of cytoplasmic and nuclear polypeptides induced by interferon‐γ in a murine pre‐B cell leukemia. Eur J Immunol 1989;19(7):1171-1176.
(222) Caruso A, Foresti I, Gribaudo G, Bonfanti C, Pollara P, Dolei A, et al. Anti-interferon-γ antibodies in sera from HIV infected patients. J BIOL REGUL HOMEOSTATIC AGENTS 1989;3(1):8-12.
(223) Zucca M, Fiscella M, Gribaudo G, Musso T, Cavallo G, Landolfo S. Biological activity of gamma interferon on various cell types in human and murine systems. G Batteriol Virol Immunol 1989;82(1-12):82-87.
(224) Zucca M, Gribaudo G, Ferrara B, Cavallo G, Landolfo S. Interferon gamma does not induce antiviral resistance in T lymphocytes. J BIOL REGUL HOMEOSTATIC AGENTS 1988;2(1):15-18.
(225) Fassio A, Gariglio M, Cofano F, Cavallo G, Landolfo S. Functional Characterization of Murine Cell Lines Expressing High, Intermediate, or Negative Levels of Surface Receptors for Interferon-γ. J Interferon Res 1988;8(3):333-341.
(226) Landolfo S, Gariglio M, Gribaudo G, Jemma C, Giovarelli M, Cavallo G. Interferon‐γ is not an antiviral, but a growth‐promoting factor for t lymphocytes. Eur J Immunol 1988;18(4):503-510.
(227) Zanovello P, Vallerani E, Biasi G, Landolfo S, Collavo D. Monoclonal antibody against IFN-γ inhibits Moloney murine sarcoma virus-specific cytotoxic T lymphocyte differentiation. J Immunol 1988;140(4):1341-1344.
(228) Gariglio M, Franco A, Cavallo G, Landolfo S. Evidence for a GTP-Binding Protein Involved in Interferon-γ Transduction Signal. J Interferon Res 1988;8(4):463-472.
(229) Frasca D, Adorini L, Landolfo S, Doria G. Enhancement of suppressor T cell activity by injection of anti-IFN-γ monoclonal antibody. J Immunol 1988;140(12):4103-4107.
(230) Giovarelli M, Santoni A, Jemma C, Musso T, Giuffrida AM, Cavallo G, et al. Obligatory role of IFN-γ in induction of lymphokine-activated and T lymphocyte killer activity, but not in boosting of natural cytotoxicity. J Immunol 1988;141(8):2831-2836.
(231) Prat M, Bretti S, Amedeo M, Landolfo S, Comoglio PM. Monoclonal antibodies against murine IFN-γ abrogate in vivo tumor immunity against RSV-induced murine sarcomas. J Immunol 1987;138(12):4530-4533.
(232) Savoia D, Landolfo S. Modulation of the adherence of group A streptococci to murine cells. Microbiologica 1987;10(3):281-290.
(233) Gribaudo G, Di Renzo F, Naldini L, Comoglio PM, Cavallo G, Landolfo S. Interferon-γ inhibits cell replication, but not pp60(src) activity of RSV-transformed fibroblasts. Microbiologica 1987;10(1):47-53.
(234) Fassio A, Cofano F, Cavallo G, Landolfo S. Activation of protein kinase C down-regulates IFN-gamma receptors. Biochem Biophys Res Commun 1987;144(1):337-344.
(235) Gribaudo G, Cocciolo MG, Cavallo G, Landolfo S. Production of polyclonal antibodies against the 40 kDa form of human 2'-5' oligoadenylate synthetase. J Biol Regul Homeost Agents 1987;1(3):143-146.
(236) Gandino L, Gribaudo G, Ghezzi P, Landolfo S. Time-dependent differential effects of natural and recombinant murine interferon-gamma on ornithine decarboxylase activity of tumor cells. J Biochem 1987;101(4):927-932.
(237) Gariglio M, Franco A, Gribaudo G, Martinotti MG, Landolfo S, Cavallo G. Cefonicid toxicity. I. Effects on the reactivity of the specific immune system. G Batteriol Virol Immunol 1987;80(1-12):225-230.
(238) Cofano F, Fassio A, Cavallo G, Landolfo S. Binding of murine 125I-labelled natural interferon-gamma to murine cell receptors. J Gen Virol 1986;67:Pt 6/.
(239) Gariglio M, Cavallo G, Landolfo S. Modulation of the action of interferon-gamma by protein G. G Batteriol Virol Immunol 1986;79(7-12):199-203.
(240) Giovarelli M, Cofano F, Vecchi A, Forni M, Landolfo S, Forni G. Interferon‐activated tumor inhibition in vivo. Small amounts of interferon‐gamma inhibit tumor growth by eliciting host systemic immunoreactivity. Int J Cancer 1986;37(1):141-148.
(241) RAMBALDI A, ROSSI V, ALLAVENA P, INTRONA M, LANDOLFO S, BASSAN R, et al. Lymphokine Production in Ty Lymphoproliferative Disorders. Scand J Immunol 1986;23(2):183-188.
(242) Simon MM, Hochgeschwender U, Brugger U, Landolfo S. Monoclonal antibodies to interferon-γ inhibit interleukin 2-dependent induction of growth and maturation in lectin/antigen-reactive cytolytic T lymphocyte precursors. J Immunol 1986;136(8):2755-2762.
(243) Simon MM, Landolfo S, Diamantstein T, Hochgeschwender U. Antigen- and lectin-sensitized murine cytolytic T lymphocyte-precursors require both interleukin 2 and endogenously produced immune (gamma) interferon for their growth and differentiation into effector cells. Curr Top Microbiol Immunol 1986;126:173-185.
(244) Savoia D, Cofano F, Landolfo S. A method for the rapid detection of streptococcal group A antigen by specific monoclonal antibody. Boll Ist Sieroter Milan 1986;65(1):69-72.
(245) Cofano F, Fassio A, Cavallo G, Landolfo S. Binding of murine 125I-labelled natural interferon-γ to murine cell receptors. J Gen Virol 1986;67(6):1205-1209.
(246) Fassio A, Cofano F, Cavallo G, Landolfo S. Production of polyclonal antibodies against the cellular IFN-gamma receptor. G Batteriol Virol Immunol 1986;79(1-6):161-168.
(247) Gribaudo G, Cofano F, Prat M, Baiocchi C, Cavallo G, Landolfo S. Natural murine interferon-γ. J Biol Chem 1985;260(17):9936-9940.
(248) Landolfo S, Cofano F, Giovarelli M, Prat M, Cavallo G, Forni G. Interferon-γ plays a crucial role in T lymphocyte reaction against alloantigens. La Ricerca in Clin Lab 1985;15(4):307-314.
(249) Ghezzi P, Bianchi M, Gianera L, Landolfo S, Salmona M. Role of Reactive Oxygen Intermediates in the Interferon-mediated Depression of Hepatic Drug Metabolism and Protective Effect of N-Acetylcysteine in Mice. Cancer Res 1985;45(8):3444-3447.
(250) Cofano F, Fassio A, Fava L, Cavallo G, Landolfo S. Characterization of the receptor for murine gamma interferon. G Batteriol Virol Immunol 1985;78(7-12):155-161.
(251) Reininger L, Fueri J, Boned A, Prat M, Landolfo S, Rubin B. On the molecular basis of T-helper-cell function. IV. B-lymphocyte-promotor factors: On their mode of action, biochemical nature and possible relationship to molecules involved in specific T-helper-cell activity. Cell Immunol 1985;92(1):85-104.
(252) Cofano F, Savoia D, Angeretti A, Cavallo G, Landolfo S. Production of monoclonal antibodies against the carbohydrate of group A streptococci. Microbiologica 1985;8(1):23-30.
(253) Reininger L, Fueri J, Boned A, Prat M, Landolfo S, Rubin B. On the molecular basis of T-helper-cell function IV. B-lymphocyte-promotor fractors: On their mode of action, biochemical nature and possible relationship to molecules involved in specific T-helper-cell activity. Cell Immunol 1985;92(1):85-104.
(254) Landolfo S, Cavallo G. Interferon γ: An immunological slant. Ann Inst Pasteur Immunol 1985;136(1):84-91.
(255) Landolfo S, Cofano F, Giovarelli M, Prat M, Cavallo G, Forni G. Inhibition of interferon-gamma may suppress allograft reactivity by T lymphocytes in vitro and in vivo. Science 1985;229(4709):176-179.
(256) Gribaudo G, Negro Ponzi A, Cavallo G, Landolfo S. Purification and physico-chemical characterization of immune (γ) interferon produced by a mouse tumor cell line. Ig Mod 1985;83(2):266-270.
(257) Landolfo S, Gribaudo G, Cofano F. Monoclonal antibodies to murine interferon gamma. Ig Mod 1985;83(2):271-274.
(258) Cofano F, Tarone G, Cavallo G, Landolfo S. Enhanced fibronectin production by murine Interferon Gamma. Ig Mod 1985;83(2):275-280.
(259) Gribaudo G, Cofano F, Prat M, Landolfo S. Monoclonal Antibodies to Murine Interferon-γ: Affinity Purification and Molecular Characterization of Murine Interferon-γ. J Interferon Res 1985;5(1):199-208.
(260) Frasca D, Adorini L, Landolfo S, Doria G. Enhancing effect of IFN-γ on helper T cell activity and IL 2 production. J Immunol 1985;134(6):3907-3911.
(261) Rambaldi A, Introna M, Colotta F, Landolfo S, Colombo N, Mangioni C, et al. Intraperitoneal administration of interferon β in ovarian cancer patients. Cancer 1985;56(2):294-301.
(262) Pischedda F, Landolfo S, Kirchner H. Lack of inhibition of mitogen‐induced lymphoproliferation by interferon gamma. Eur J Immunol 1985;15(4):413-415.
(263) Landolfo S, Cofano F, Gandino L, Gribaudo G, Prat M. Monoclonal antibodies against mouse γ-interferon inhibit tumoricidal macrophage activation by T lymphocytes1. Pathobiology 1985;53(5):265-269.
(264) Cofano F, Fassio A, Cavallo G, Landolfo S. Analysis of the gamma interferon receptor in mice. G Batteriol Virol Immunol 1985;78(1-6):70-76.
(265) Cofano F, Comoglio PM, Landolfo S, Tarone G. Mouse immune interferon enhances fibronectin production of elicited macrophages. J Immunol 1984;133(6):3102-3106.
(266) Gribaudo G, Cofano F, Gandino L, Cavallo G, Landolfo S. Electrophoretic mobility of mouse immune (gamma) interferon produced by a cloned T-cell lymphoma. Microbiologica 1984;7(4):309-313.
(267) Cofano F, Fassio A, Cavallo G, Landolfo S. Production of anti-idiotypic monoclonal antibodies that recognize the receptor for murine gamma interferon. G Batteriol Virol Immunol 1984;77(7-12):215-219.
(268) Landolfo S, Cavallo G, Comoglio PM, Prat M. Monoclonal antibodies against murine interferon-y (IFN-y). Fed Proc 1984;43(6).
(269) Prat M, Gribaudo G, Comoglio PM, Cavallo G, Landolfo S. Monoclonal antibodies against murine γ interferon. Proc Natl Acad Sci U S A 1984;81(14 I):4515-4519.
(270) Biondi A, Landolfo S, Fumaroa D, Polentarutti N, Introna M, Mantovani A. Evaluation of absorption with Limulus amebocyte lysate to remove contaminating endotoxin from interferon and lymphokine preparations. J Immunol Methods 1984;66(1):103-112.
(271) Gribaudo G, Cofano F, Cavallo GP, Boggio F, Landolfo S. Gamma-interferon: physico-chemical and biological characteristics. G Batteriol Virol Immunol 1984;77(1-6):86-93.
(272) Savoia D, Cofano F, Cavallo G, Landolfo S. Effect of gamma-interferon on the adherence of streptococci to different murine cell lines. G Batteriol Virol Immunol 1984;77(1-6):113-122.
(273) Marcucci F, Klein B, Altevogt P, Landolfo S, Kirchner H. Concanavalin A-Induced Interferon Gamma Production by Murine Spleen Cells and T Cell Lines. Lack of Correlation with Lyt 1, 2 Phenotype. Immunobiology 1984;166(3):219-227.
(274) Gribaudo G, Cofano F, Negro Ponzi A, Landolfo S. Mouse Gamma Interferon Produced by a Cloned T-Cell Lymphoma. I. Purification and Physicochemical Characterization. J Interferon Res 1984;4(1):91-99.
(275) RUBIN B, REININGER L, SUZAN M, FUERI J, DENIZOT F, LANDOLFO S, et al. On the Molecular Basis of T Helper Cell Function: III. B‐Lymphocyte Promoter Factors: Production by T Hybridoma and Tumour Cells; Preliminary Biochemical Characterization. Scand J Immunol 1984;19(6):563-573.
(276) Cortesina G, Bussi M, Morra B, Beatrice F, Cavallo GP, Di Fortunato V, et al. Evaluation of the immune responsiveness in laryngeal cancer patients with specific and aspecific tests: first results of follow-up in 80 cases. G Batteriol Virol Immunol 1983;76(7-12):173-186.
(277) Landolfo S, Balzi E, Sarzotti M, Negro-Ponzi A, Arnold B. Some characteristics of mouse immune (y) interferon produced by a T-lymphoma cell line. Microbiologica 1983;6(2):101-106.
(278) Cortesina G, Bussi M, Morra B, Beatrice F, Cavallo GP, Di Fortunato V, et al. Specific LIF production in laryngeal cancer patients: evidence of suppressor activity exerted by adherent cells. Tumori 1983;69(6):497-502.
(279) Landolfo S, Kirchner H. Comparison with monoclonal anti‐Ia antibodies of antigenic determinants inducing lymphocyte proliferation and immune interferon production in primary and secondary murine mixed lymphocyte reactions. Eur J Immunol 1983;13(1):78-82.
(280) Berger R, Landolfo S, Balzi E, Kirchner H. Production of Interferon-Gamma in the Syngeneic Mixed Lymphocyte Reaction. Immunobiology 1983;165(2):225-233.
(281) Martinotti MG, Cofano F, Martinetto P, Landolfo S. Natural macrophage cytotoxicity against Trichomonas vaginalis is mediated by soluble lytic factors. Infect Immun 1983;41(3):1144-1149.
(282) Sarzotti M, Landolfo S, Dianzani F. Immune (gamma) interferon production by a murine T cell lymphoma: Requirements for macromolecular synthesis and lack of relationship with cell cycle. Infect Immun 1983;41(2):624-630.
(283) Cofano F, Gribaudo G, Tarone G, Landolfo S. Increase of fibronectin-dependent phagocytosis by immune interferon of the mouse. G Batteriol Virol Immunol 1983;76(1-6):104-108.
(284) Martinotti MG, Gallione MA, Martinetto P, Landolfo S. Role of cytoskeleton in natural cell-mediated cytotoxicity against Trichomonas vaginalis. Microbiologica 1982;5(4):389-391.
(285) Gribaudo G, Cavallo GP, Capunzo M, Negro-Ponzi A, Landolfo S. Structural characteristics of mouse immune interferon. Boll Ist Sieroter Milan 1982;61(6):483-486.
(286) Giovarelli M, Landolfo S, Scher I, Forni G. Distinct alloantigens trigger proliferative or nonproliferative T lymphocyte activation in CBA/N, CBA/J, and C3H mice. Transplantation 1982;33(3):260-264.
(287) Landolfo S, Arnold B, Suzan M. Immune (y) interferon production by murine T cell lymphomas. J Immunol 1982;128(6):2807-2809.
(288) Giovarelli M, Landolfo S, Whitmore AC, Forni G. Rous sarcoma virus-induced tumors in mice-I. Macrophage-mediated natural cytotoxicity. Eur J Cancer Clin Oncol 1982;18(3):307-315.
(289) Schirrmacher V, Landolfo S, Zawatzky R, Kirchner H. Immunogenetic studies on the resistance of mice to highly metastatic DBA/2 tumor cell variants. II. Influence of minor histocompatibility antigens on tumor resistance, gamma-interferon induction and cytotoxic response. Invasion Metastasis 1982;1(3):175-194.
(290) Landolfo S, Kirchner H, Simon MM. Production of immune interferon is regulated by more than one T cell subset: Lyt‐1,2,3 and Qat‐5 phenotypes of murine T lymphocytes involved in IFN‐γ production in primary and secondary mixed lymphocyte reaction. Eur J Immunol 1982;12(4):295-299.
(291) Forni G, Landolfo S, Giovarelli M, Whitmore AC, Herberman RB. Immune recognition of tumor cells in vivo. I. Role of H‐2 gene products in T lymphocyte activation against minor histocompatibility antigens displayed by adenocarcinoma cells. Eur J Immunol 1982;12(8):664-670.
(292) Mantovani A, Polentarutti N, Peri G, Martinotti G, Landolfo S. Cytotoxicity of human peripheral blood monocytes against Trichomonas vaginalis. Clin Exp Immunol 1981;46(2):391-396.
(293) Martinotti MG, Forni M, Del Monte AM, Giovarelli M, Landolfo S. Immune depression in Trypanosoma brucei brucei infected mice. Sequential histological and immunological findings. Boll Ist Sieroter Milan 1981;60(4):288-296.
(294) Martinotti MG, Landolfo S. Development of special research programs onparasitoses and tropical diseases. G Batteriol Virol Immunol 1981;74(1-6):181-188.
(295) Cavallo G, Landolfo S. Macrophages. G Batteriol Virol Immunol 1981;74(7-12):213-223.
(296) Sarzotti M, Landolfo S. Characteristics of cells producing immune interferon. G Batteriol Virol Immunol 1981;74(7-12):224-228.
(297) Forni G, Giovarelli M, Giovanna Martinotti M, Landolfo S. Evolution of macrophage immune recognition of viral, bacterial, protozoal and allo-antigens. Dev Comp Immunol 1981;5(SUPPL. 1):61-66.
(298) Landolfo S, Marcucci F, Schirrmacher V, Kirchner H. Characteristics of Alloantigens and Cellular Mechanisms Responsible for Gamma-Interferon Production in Primary Murine MLC. J Interferon Res 1981;1(3):339-345.
(299) Landolfo S, Martinotti MG, Martinetto P, Forni G, Rabagliati AM. Trichomonas vaginalis: Dependence of resistance among different mouse strains upon the non-H-2 gene haplotype, sex, and age of recipient hosts. Exp Parasitol 1981;52(3):312-318.
(300) Giovarelli M, Martinotti MG, Cavallo GP, Landolfo S. Lyt phenotype of T-lymphocytes producing migration inhibitory factor (MIF) in primary murine mixed lymphocyte culture. Boll Ist Sieroter Milan 1981;60(2):110-112.
(301) Martinotti MG, Martinetto P, Landolfo S. Effect of estradiol on natural resistance: In vivo and in vitro studies. Microbiologica 1981;4(2):181-186.
(302) Cavallo GP, Landolfo S. Biologic aspects of macrophage migration inhibitory factor. G Batteriol Virol Immunol 1980;73(7-12):196-201.
(303) Fiori GP, Rabagliati AM, Landolfo S, Penna R. Serologic study on occurrence of toxoplasmosis in a north Italian population sample. G Batteriol Virol Immunol 1980;73(7-12):299-316.
(304) Forni G, Serrati G, Giordano L, Giovarelli M, Rendine S, Landolfo S. Interaction of H-2 and non-H-2 genes in spontaneous resistance to adenocarcinoma ADK-1t in F 1 mice. J Natl Cancer Inst 1980;65(3):651-655.
(305) Landolfo S, Di Matteo C, Capusso A, Negro-Ponzi A, Forni G. Lymphokine production in primary mixed lymphocyte reactions. I. Characteristics of responding and stimulating cells. Exp Cell Biol 1980;48(3):180-190.
(306) Negro Ponzi A, Cerio E, Landolfo S. Quantitative determination of virus hemagglutination: An improved method. Microbiologica 1980;3(4):427-441.
(307) Martinotti MG, Landolfo S, Martinetto P. Hydatidosis and cysticercosis: A social and economic problem. G Batteriol Virol Immunol 1980;73(1-6):15-21.
(308) Landolfo S, Marcucci F, Giovarelli M, Forni G. Does macrophage production of interferon after alloantigen stimulation depend on factors from activated t lymphocytes. Transplantation 1980;29(1):87-89.
(309) Landolfo S, Martinotti MG, Martinetto P, Forni G. Natural cell-mediated cytotoxicity against Trichomonas vaginalis in the mouse. I. Tissue, strain, age distribution, and some characteristics of the effector cells. J Immunol 1980;124(2):508-514.
(310) Varesio L, Landolfo S, Giovarelli M, Forni G. The macrophage as the social interconnection within the immune system. Dev Comp Immunol 1980;4(C):11-19.
(311) Forni G, Varesio L, Giovarelli M, Landolfo S. Source of tumor cells influences their immune recognition by H-2-matched mice. Transplantation 1979;27(6):433-435.
(312) Landolfo S, Martinotti MG, Martinetto P, Forni G. Genetic control of Trichomonas vaginalis infection. I. Resistance or susceptibility among different mouse strains. Boll Ist Sieroter Milan 1979;58(1):48-51.
(313) Landolfo S, Giovarelli M, Capusso A, Forni G. Lymphokine production in primary mixed lymphocyte culture (MLC). III. Alloantigen signals and cell-cell interactions involved in migration inhibition factor and immune interferon release. Boll Ist Sieroter Milan 1979;58(2):128-132.
(314) Forni G, Giovarelli M, Negro-Ponzi A, Landolfo S. H-2-restriction and Ia-dependence of the efficient immune recognition of minor histocompatibility antigens in vivo. Immunogenetics 1979;9(1):199-202.
(315) Landolfo S, Marcucci F, Giovarelli M, Viano I, Forni G. Lymphokine production in mouse mixed lymphocyte reaction (MLR) - II. Tentative mapping of murine alloantigens activating migration inhibition factor and interferon release and their relationship with those, activating proliferative response. Immunogenetics 1979;9(1):245-253.
(316) Varesio L, Giovarelli M, Landolfo S, Forni G. Suppression of Proliferative Response and Lymphokine Production during the Progression of a Spontaneous Tumor. Cancer Res 1979;39(12):4983-4988.
(317) Landolfo S, Giovarelli M, Forni G. Alloantigen requirements for nonproliferative activation of T lymphocytes. Transplantation 1979;27(4):288-290.
(318) Landolfo S, Giovarelli M, Martinotti MG, Varesio L, Cappuccinelli P. Enhancement versus tumor resistance induced by different levels of immunodepression in BALB/c mice with protozoan infections. European Journal of Cancer (1965) 1979;15(1):27-33.
(319) Landolfo S, Giovarelli M, Forni G. Alloantigen requirements for nonproliferative activation of T lymphocytes. Transplantation 1979;27(4):290-291.
(320) Landolfo S, Herberman RB, Holden HT. Macrophage-lymphocyte interaction in migration inhibition factor (MIF) production against soluble or cellular tumor-associated antigens. I. Characteristics and genetic control of two different mechanisms of stimulating MIF production. J Immunol 1978;121(2):695-701.
(321) Landolfo S, Martinetto P, Cavallo G. The parasite-host relationship: An immunological game. G Batteriol Virol Immunol 1978;71(7-12):192-197.
(322) Cavallo G, Giovarelli M, Forni G, Landolfo S. Is antibody-dependent cellular cytotoxicity an important mechanism of resistance to tumors in vivo? Mol Immunol 1978;15(10-11):801-805.
(323) Varesio L, Landolfo S, Cavallo G. Kinetics of antibody response in unprimed recipients after transfer of immune lymphocytes. Folia Biol (Praha) 1978;24(4):264-269.
(324) Landolfo S, Herberman RB, Holden HT. Two mechanisms of migration inhibition factor induction by tumour antigens. Nature 1977;270(5632):62-64.
(325) Landolfo S. Macrophage inhibitory factor (MIF): Properties and role in delayed-type hypersensitivity. G Batteriol Virol Immunol 1977;70(7-12):137-143.
(326) Landolfo S, Herberman RB, Holden HT. Stimulation of mouse migration inhibitory factor (MIF) production from MSV immune lymphocytes by soluble tumor associated antigen: requirement for histocompatible macrophages. J Immunol 1977;118(4):1244-1248.
(327) Holden HT, Landolfo S, Herberman RB. T-cell-dependent reactivity against tumor-associated antigens on allogeneic target cells. Transplant Proc 1977;9(1):1149-1152.
(328) Landolfo S, Giovarelli M, Forni G. In vitro arming and blocking activity of sera from BALB/c mice bearing a spontaneous transplantable adenocarcinoma. European Journal of Cancer (1965) 1977;13(11):1217-1223.
(329) Landolfo S, Herberman RB, Holden HT. Cellular immunity to murine sarcoma virus induced tumors as measured by macrophage migration inhibition assays. J Natl Cancer Inst 1977;59(6):1675-1683.
(330) Landolfo S, Pugliese A. Effects of a synthetic peptide on the cytotoxic activity of lymphocytes from tumour bearing animals. G Batteriol Virol Immunol 1975;68(7-12):240-246.
(331) Prat M, Landolfo S, Comoglio PM. Neuraminidase sensitive antigenic determinants of plasma cell tumor membrane glycoproteins. FEBS Lett 1975;51(1-2):351-354.
(332) Cappuccinelli P, Giovarelli M, Landolfo S. Immunodepression in mice infected with Trypanosoma congolense and Trichomonas vaginalis. G Mal Infett Parassit 1975;27(8):788-791.
(333) Landolfo S. Monolayer cultures of transplantable tumors for cytotoxicity tests in vitro. G Batteriol Virol Immunol 1973;66:I/7-12.